EPS

Since its establishment in 1991, EPS Corporation, as a pioneering CRO, has become a healthcare solutions provider for pharmaceutical companies, medical device manufacturers, hospitals and clinics, and academia. It offers a variety of solutions from development to marketing, sales, and consulting, covering Asia and creating new value in areas such as big data, artificial intelligence, and regenerative medicine. EPS's advantage lies in its largest market share in Japan. In Asia, the company has multiple overseas offices and is particularly focused on consolidating its sites in respective Asian countries, providing clinical development support services as well as SMO services.